| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | N Mechawar | |
| J Savitz | |||
| P2860 | cites work | Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. | Q47969861 |
| Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder | Q48053565 | ||
| Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides | Q48081647 | ||
| Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors | Q48106435 | ||
| Peripheral inflammation during abnormal mood states in bipolar I disorder | Q36103950 | ||
| Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. | Q36155325 | ||
| Toxoplasma gondii Infections Alter GABAergic Synapses and Signaling in the Central Nervous System | Q36227285 | ||
| Loneliness, eudaimonia, and the human conserved transcriptional response to adversity | Q36260185 | ||
| Microglia in the TBI brain: The good, the bad, and the dysregulated. | Q36399682 | ||
| Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene | Q36525031 | ||
| The glutamate-glutamine cycle as an inducible, protective face of macrophage activation | Q36567120 | ||
| L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation | Q36618166 | ||
| Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities | Q36625412 | ||
| Glial reduction in the subgenual prefrontal cortex in mood disorders | Q36651128 | ||
| Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord | Q36691900 | ||
| Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration | Q36806349 | ||
| Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder | Q36812629 | ||
| Autoimmune Encephalitis in Postpartum Psychosis | Q36862598 | ||
| Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression | Q36889327 | ||
| Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. | Q36946523 | ||
| Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients | Q36948381 | ||
| NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice | Q37030206 | ||
| Glucose metabolism in the insula and cingulate is affected by systemic inflammation in humans | Q37030301 | ||
| Elevated cytokine expression in the orbitofrontal cortex of victims of suicide | Q37032702 | ||
| Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder | Q37061873 | ||
| Smaller Dentate Gyrus and CA2 and CA3 Volumes Are Associated with Kynurenine Metabolites in Collegiate Football Athletes. | Q37062133 | ||
| Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder | Q37083101 | ||
| Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression | Q37104018 | ||
| Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression | Q37128042 | ||
| Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior | Q37128151 | ||
| Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia | Q37149873 | ||
| Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis | Q37258132 | ||
| A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta | Q37300227 | ||
| Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals | Q37370987 | ||
| GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression | Q37408446 | ||
| Regulation of innate immune responses in the brain | Q37492253 | ||
| Glutamate normalization with ECT treatment response in major depression | Q37495562 | ||
| Increased levels of glutamate in brains from patients with mood disorders. | Q48133783 | ||
| Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders | Q48137205 | ||
| Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment | Q48137846 | ||
| The longitudinal association between inflammation and incident depressive symptoms in men: the effects of hs-CRP are independent of abdominal obesity and metabolic disturbances | Q48161624 | ||
| Treatment-Resistant Depression and Aquaporin-4 Autoantibodies: Is There a Link? | Q48166239 | ||
| Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex | Q48182423 | ||
| Prenatal inhibition of the tryptophan-kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus | Q48192643 | ||
| Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls | Q48204136 | ||
| A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality | Q48233112 | ||
| Evidence for a neuroinflammatory mechanism in delayed effects of early life adversity in rats: relationship to cortical NMDA receptor expression | Q48269132 | ||
| Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides | Q48288128 | ||
| Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide | Q48335595 | ||
| Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients | Q48357784 | ||
| Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients | Q48433920 | ||
| Astrocytic complexity distinguishes the human brain | Q48434985 | ||
| Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines | Q48440751 | ||
| Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia | Q48479959 | ||
| Autoimmunity in psychiatry | Q48536905 | ||
| Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders | Q48689946 | ||
| Electron microscopy of oligodendroglia in severe mental illness. | Q48772850 | ||
| Seroprevalence of autoantibodies against brain antigens in health and disease | Q48774317 | ||
| Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia | Q48891579 | ||
| Association of high-sensitivity C-reactive protein with de novo major depression | Q48972863 | ||
| Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder | Q49110783 | ||
| Human social genomics | Q21092402 | ||
| The myth of schizophrenia as a progressive brain disease | Q24067152 | ||
| Is Toxoplasma Gondii Infection Related to Brain and Behavior Impairments in Humans? Evidence from a Population-Representative Birth Cohort | Q24288638 | ||
| In psychosis, cortical interneurons overexpress DNA-methyltransferase 1 | Q24556666 | ||
| Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis | Q24614608 | ||
| Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity | Q24634258 | ||
| GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia | Q24642711 | ||
| Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder | Q24647600 | ||
| Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis | Q24656702 | ||
| Effects of Toxoplasma gondii infection on the brain | Q24656964 | ||
| Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue | Q26827833 | ||
| Quinolinic acid, the inescapable neurotoxin | Q26991715 | ||
| A putative functional role for oligodendrocytes in mood regulation | Q26995174 | ||
| Current approaches to enhance glutamate transporter function and expression | Q26996723 | ||
| Microglial interactions with synapses are modulated by visual experience | Q27322943 | ||
| The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. | Q27863346 | ||
| Antibody-mediated encephalitis: a treatable cause of schizophrenia | Q28258673 | ||
| Schizophrenia risk from complex variation of complement component 4 | Q28272545 | ||
| White matter tractography in bipolar disorder and schizophrenia | Q28295103 | ||
| Physiology of microglia | Q29547414 | ||
| Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study | Q29616193 | ||
| A meta-analysis of cytokines in major depression | Q29617325 | ||
| Microglial physiology: unique stimuli, specialized responses | Q29620417 | ||
| Adult oligodendrocyte progenitor cells - Multifaceted regulators of the CNS in health and disease | Q30277699 | ||
| IL-4 in the brain: a cytokine to remember | Q30416623 | ||
| Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain | Q30584811 | ||
| Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network | Q30772377 | ||
| Finding the Elusive Psychiatric "Lesion" With 21st-Century Neuroanatomy: A Note of Caution | Q30990470 | ||
| Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research | Q30995022 | ||
| Kynurenines in the CNS: from endogenous obscurity to therapeutic importance | Q32148941 | ||
| Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients | Q33226446 | ||
| Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. | Q33289670 | ||
| Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. | Q51943076 | ||
| High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. | Q51957863 | ||
| Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. | Q53071540 | ||
| Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population. | Q53392930 | ||
| White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging | Q57316787 | ||
| SnapShot: Stress and Disease | Q61200307 | ||
| Activated human microglia produce the excitotoxin quinolinic acid | Q73175992 | ||
| Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain | Q73447770 | ||
| Are autoimmune thyroid dysfunction and depression related? | Q77325012 | ||
| The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS | Q77846814 | ||
| Meta-analysis of 12 genomic studies in bipolar disorder | Q80860524 | ||
| Neuropsychiatric manifestations of multiple sclerosis | Q81957990 | ||
| The activation of monocyte and T cell networks in patients with bipolar disorder | Q83737091 | ||
| Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies | Q86153175 | ||
| Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration | Q86492751 | ||
| Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder | Q33355898 | ||
| Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars | Q33395226 | ||
| The excitotoxin quinolinic acid induces tau phosphorylation in human neurons | Q33485236 | ||
| Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression | Q33492323 | ||
| Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression | Q33553152 | ||
| A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers | Q33587452 | ||
| IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy | Q33620624 | ||
| Uniquely hominid features of adult human astrocytes | Q33644376 | ||
| Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies | Q33664090 | ||
| Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients | Q33751063 | ||
| High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance | Q33814536 | ||
| Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder | Q33846348 | ||
| Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder | Q33978656 | ||
| N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial | Q34012103 | ||
| Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression? | Q34051382 | ||
| Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression | Q34065490 | ||
| System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo | Q34073426 | ||
| Microglia of prefrontal white matter in suicide | Q34076322 | ||
| Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression | Q34084102 | ||
| Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression | Q34084772 | ||
| Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders | Q34088066 | ||
| Inflammation-associated depression: from serotonin to kynurenine | Q34147377 | ||
| Autoimmune diseases, bipolar disorder, and non-affective psychosis | Q34179648 | ||
| Peripheral inflammation acutely impairs human spatial memory via actions on medial temporal lobe glucose metabolism | Q34199733 | ||
| Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders | Q34204211 | ||
| Oligodendrocyte dysfunction in schizophrenia and bipolar disorder | Q34246905 | ||
| An open-label trial of riluzole in patients with treatment-resistant major depression | Q34287364 | ||
| Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha | Q34323973 | ||
| Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder | Q34331509 | ||
| Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis | Q34352492 | ||
| Antibodies to Toxoplasma gondii in individuals with mania | Q34376089 | ||
| Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia | Q34471254 | ||
| Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder | Q34480323 | ||
| Morphometric characterization of microglial phenotypes in human cerebral cortex | Q37532369 | ||
| Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain | Q37555027 | ||
| Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia | Q37580309 | ||
| Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder | Q37621319 | ||
| Astrocytic abnormalities and global DNA methylation patterns in depression and suicide | Q37626767 | ||
| Familial comorbidity of bipolar disorder and multiple sclerosis: genetic susceptibility, coexistence or causal relationship? | Q37627409 | ||
| Toll-like receptors in the depressed and suicide brain | Q37731799 | ||
| Neurobiology of injury to the developing brain | Q37755972 | ||
| Inflammation, demyelination, and degeneration - recent insights from MS pathology. | Q37773548 | ||
| Clinical depression and inflammatory risk markers for coronary heart disease | Q37870585 | ||
| Inflammation, depressive symptomtology, and coronary artery disease | Q37875574 | ||
| Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link | Q37905722 | ||
| Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis | Q38114586 | ||
| Crying and suicidal, but not depressed. Pseudobulbar affect in multiple sclerosis successfully treated with valproic acid: Case report and literature review | Q38219309 | ||
| Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders. | Q38305248 | ||
| Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. | Q38425887 | ||
| The role of inflammation in depression: from evolutionary imperative to modern treatment target | Q38681725 | ||
| Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions | Q38724866 | ||
| Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor | Q39396414 | ||
| Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers | Q39542626 | ||
| Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression | Q39793664 | ||
| Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors | Q39921706 | ||
| Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. | Q40099434 | ||
| Sex differences in glutamate receptor gene expression in major depression and suicide | Q40742522 | ||
| Inflammatory evidence for the psychosis continuum model | Q40774386 | ||
| Relationship Between Toxoplasma gondii and Mood Disturbance in Women Veterans | Q41191827 | ||
| Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation. | Q41257707 | ||
| C-reactive protein alterations in bipolar disorder: a meta-analysis | Q41289839 | ||
| Response of glial cells to ischemia: roles of reactive oxygen species and glutathione | Q41377079 | ||
| Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain | Q41605555 | ||
| Reduced GABA neuron density in auditory cerebral cortex of subjects with major depressive disorder. | Q41646482 | ||
| A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle | Q42075361 | ||
| Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation | Q42216776 | ||
| Consistent associations between measures of psychological stress and CMV antibody levels in a large occupational sample. | Q42240482 | ||
| Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2. | Q42315823 | ||
| Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder | Q42604899 | ||
| Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family | Q42683853 | ||
| Alcohol dependence-related increase of glial cell density in the anterior cingulate cortex of suicide completers. | Q43105498 | ||
| Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia | Q43258935 | ||
| Stress-induced immune dysfunction: implications for health | Q43472077 | ||
| Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder | Q43593933 | ||
| Quinolinic acid-iron(ii) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction | Q43621641 | ||
| Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder | Q43890441 | ||
| The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. | Q43923756 | ||
| Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders | Q43997962 | ||
| Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia | Q44014143 | ||
| Low glial numbers in the amygdala in major depressive disorder | Q44145406 | ||
| Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes | Q44294994 | ||
| Decreased N-acetylaspartate in children with familial bipolar disorder | Q44466569 | ||
| A novel, rapid, quantitative cell-counting method reveals oligodendroglial reduction in the frontopolar cortex in major depressive disorder | Q44484522 | ||
| Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. | Q44495175 | ||
| Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism | Q45081990 | ||
| Preterm birth and psychiatric disorders in young adult life | Q45368495 | ||
| Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder | Q45497214 | ||
| National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. | Q45533092 | ||
| Successful execution of working memory linked to synchronized high-frequency gamma oscillations | Q45881657 | ||
| Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers | Q46174413 | ||
| Immune-to-brain signalling: the role of cerebral CD163-positive macrophages | Q46318926 | ||
| Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders | Q46461905 | ||
| A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. | Q46662600 | ||
| A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists | Q46703076 | ||
| Down-regulation of astrocytic GLAST by microglia-related inflammation is abrogated in dibutyryl cAMP-differentiated cultures | Q46734834 | ||
| Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder | Q46886163 | ||
| Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder | Q46974964 | ||
| Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. | Q47191236 | ||
| Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. | Q47207451 | ||
| Stress, loneliness, and changes in herpesvirus latency | Q47601943 | ||
| Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward | Q34514025 | ||
| Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes | Q34582826 | ||
| Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder? | Q34586552 | ||
| Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder | Q34588846 | ||
| Pseudobulbar affect: prevalence and management | Q34658447 | ||
| The role of NMDA receptors in the pathophysiology and treatment of mood disorders. | Q34664587 | ||
| Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. | Q34667721 | ||
| Are some cases of psychosis caused by microbial agents? A review of the evidence | Q34749296 | ||
| Distribution of parvalbumin and calretinin immunoreactive interneurons in motor cortex from multiple sclerosis post-mortem tissue | Q34754753 | ||
| Immune system to brain signaling: neuropsychopharmacological implications. | Q34769827 | ||
| Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder | Q34979782 | ||
| Treatment of cytokine-induced depression | Q34980861 | ||
| Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents | Q35012816 | ||
| The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans | Q35017005 | ||
| Distribution of vesicular glutamate transporters in the human brain | Q35149796 | ||
| Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia. | Q35154322 | ||
| Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway | Q35168537 | ||
| Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? | Q35225947 | ||
| Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims | Q35573452 | ||
| Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification | Q35581623 | ||
| Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides | Q35592026 | ||
| Environmental Basis of Autoimmunity | Q35638839 | ||
| Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder | Q35647362 | ||
| RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients | Q35662070 | ||
| Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4 | Q35705851 | ||
| Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial | Q35789318 | ||
| Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination | Q35815842 | ||
| Cytokines and psychopathology: lessons from interferon-alpha | Q35970243 | ||
| Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study | Q36032535 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| brain | Q1073 | ||
| bipolar disorder | Q131755 | ||
| nervous system | Q9404 | ||
| major depressive disorder | Q42844 | ||
| inflammation mediators | Q66765004 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e946 | |
| P577 | publication date | 2016-11-08 | |
| P1433 | published in | Translational Psychiatry | Q15716636 |
| P1476 | title | Neuropathology of mood disorders: do we see the stigmata of inflammation? | |
| P478 | volume | 6 |
| Q102323849 | A hidden menace? Cytomegalovirus infection is associated with reduced cortical gray matter volume in major depressive disorder |
| Q96230071 | A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration |
| Q58082651 | Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide |
| Q91635047 | Adult neuroplasticity: A new “cure” for major depression? |
| Q47414228 | Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder |
| Q40147546 | Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: Association with sleep disturbance |
| Q47148667 | Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models |
| Q97066977 | Antidepressant-Like Effects of Coumaroylspermidine Extract From Safflower Injection Residues |
| Q90454383 | Biological Mechanisms of Cancer-Induced Depression |
| Q64945797 | Buprenorphine: Therapeutic potential beyond substance abuse. |
| Q48192046 | Chemical interaction between Lilium brownii and Rhizoma Anemarrhenae, the herbal constituents of Baihe Zhimu decoction, by liquid chromatography coupled to hybrid triple quadrupole linear ion trap mass spectrometer. |
| Q52356865 | Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders. |
| Q64118633 | Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health |
| Q47682578 | Effects of acute systemic inflammation on the interplay between sad mood and affective cognition |
| Q47643969 | Effects of anti-inflammatory drugs on the expression of tryptophan-metabolism genes by human macrophages. |
| Q58554142 | Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective |
| Q39335649 | Heterogeneous populations of neural stem cells contribute to myelin repair. |
| Q89658753 | Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases |
| Q91856535 | Innate immunity in the postmortem brain of depressed and suicide subjects: Role of Toll-like receptors |
| Q64078645 | Integrative Analysis of DiseaseLand Omics Database for Disease Signatures and Treatments: A Bipolar Case Study |
| Q54942001 | Is poststroke depression the same as major depression? |
| Q47722395 | Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression |
| Q89723642 | Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated with Reported Early Life Adversity but Not Suicide |
| Q47140966 | Modulating Neuroinflammation to Treat Neuropsychiatric Disorders |
| Q61816652 | Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? |
| Q38694557 | Neurobehavioral comorbidities of epilepsy: Role of inflammation. |
| Q64108001 | Neurointegrity and neurophysiology: astrocyte, glutamate, and carbon monoxide interactions |
| Q38659366 | Neuropathology of suicide: recent findings and future directions. |
| Q49244418 | Neurotrophic, Cytoprotective, and Anti-inflammatory Effects of St. John's Wort Extract on Differentiated Mouse Hippocampal HT-22 Neurons |
| Q38799706 | Novel rodent model of breast cancer survival with persistent anxiety-like behavior and inflammation. |
| Q61449859 | Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse |
| Q41605478 | Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study |
| Q61806045 | Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders |
| Q39258097 | Social defeat models in animal science: What we have learned from rodent models |
| Q64257788 | Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies |
| Q93066099 | The kynurenine pathway: a finger in every pie |
| Q47648526 | Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial |
| Q64029499 | Treatment-resistant depression and peripheral C-reactive protein |
| Q47551793 | Tulsa 1000: a naturalistic study protocol for multilevel assessment and outcome prediction in a large psychiatric sample. |
| Q61444284 | Tumor resection ameliorates tumor-induced suppression of neuroinflammatory and behavioral responses to an immune challenge in a cancer survivor model |
| Q64923151 | Unravelling the GSK3β-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder. |
| Q33829223 | cAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress |
Search more.